Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
regulatory(beta) subunit of casein kinase II\; plays a role as a docking site for a subset of CK2 substrates [RGD, Feb 2006].. Zusätzlich bieten wir Ihnen Casein Kinase 2, alpha Prime Polypeptide Antikörper (73) und Casein Kinase 2, alpha Prime Polypeptide Kits (9) und viele weitere Produktgruppen zu diesem Protein an.
Showing 9 out of 11 products:
Human CSNK2A2 Protein expressed in Baculovirus infected Insect Cells - ABIN2215379
Peng, Wang, Hu, Zhao, Hou, Zhao, Wang, Liao, Xu: Modulation of LSD1 phosphorylation by CK2/WIP1 regulates RNF168-dependent 53BP1 recruitment in response to DNA damage. in Nucleic acids research 2015
The influence of the combined treatment on apoptosis in leukemia cells, as well as on cell-cycle progression and the levels of TS, CK2alpha and P-Ser529-p65 (zeige GORASP1 Proteine) were determined.
CK2 (zeige CSNK2A1 Proteine) is required to mediate FXR (zeige NR1H4 Proteine) SUMOylation.
this study shows that breakpoint cluster region protein (zeige BCR Proteine) regulates inflammation development via the alpha subunit of casein kinase II (zeige CSNK2A1 Proteine)
we identify a therapeutically exploitable posttranslational mechanism by which CK2alpha-mediated degradation of BRMS1 (zeige BRMS1 Proteine) promotes metastases in lung cancer
These data support a role for casein kinase 2 in regulation of protein synthesis by downregulating stress granule formation through G3BP1 (zeige G3BP1 Proteine).
In this study, the disordered feature of Nopp140 (zeige NOLC1 Proteine) and the effect of CK2alpha on the structure of Nopp140 (zeige NOLC1 Proteine) were examined using single-molecule fluorescence resonance energy transfer (smFRET) and electron paramagnetic resonance (EPR (zeige EREG Proteine)).
KLF4 (zeige KLF4 Proteine) acts as a tumor suppressor or oncogene (zeige RAB1A Proteine) to activate or repress target gene transcription depending on its acetylation status, which is regulated by p21 (zeige CDKN1A Proteine) and CK2 (zeige CSNK2A1 Proteine) interaction-mediated HDAC2 (zeige HDAC2 Proteine) phosphorylation
CK2 (zeige CSNK2A1 Proteine) is widely expressed in follicular, Burkitt and diffuse large B-cell lymphomas and may have role in malignant B-cell growth.
We conclude that this class of chimeric peptides, in addition to altering some properties of CK2 (zeige CSNK2A1 Proteine) holoenzyme, affects several other cellular targets, causing profound perturbations of cell biology
Over-expressed CK2alpha positively regulate Hh/Gli1 (zeige GLI1 Proteine) signaling in human mesothelioma.
We found that C/EBPbeta (zeige CEBPB Proteine) is phosphorylated by CK2 (zeige CSNK2A1 Proteine) under AMPK (zeige PRKAA1 Proteine) suppression and ER stress, which are important from the viewpoint of the worsening pathological condition of type 2 diabetes, such as decreased insulin (zeige INS Proteine) secretion and apoptosis of pancreatic beta cells/
Data (including data from studies using knockout mice) suggest that Brg1 (zeige SMARCA4 Proteine) is phosphorylated by casein kinase 2 (Ck2 (zeige CSNK2A1 Proteine); Ck2alpha1 and Ck2alpha-prime are catalytic subunits) in proliferating skeletal myoblasts; Brg1 (zeige SMARCA4 Proteine) is catalytic subunit of SWI (zeige SMARCA1 Proteine)/SNF (zeige SNRPA Proteine) chromatin-remodeling enzymes; Ck2 (zeige CSNK2A1 Proteine)-mediated phosphorylation of Brg1 (zeige SMARCA4 Proteine) appears to regulate myoblast proliferation. (Brg1 (zeige SMARCA4 Proteine) = Brahma (zeige SMARCA2 Proteine)-related gene 1 protein)
data implicate CK2 (zeige CSNK2A1 Proteine) as a regulator of the Th17/Treg axis and Th17 cell maturation and suggest that CK2 (zeige CSNK2A1 Proteine) could be targeted for the treatment of Th17 cell-driven autoimmune disorders.
CD5-CK2 signaling axis regulates positive selection by modulating activation of ERK and promoting survival independent of proximal TCR signals
This study shows for the first time that LPS (zeige TLR4 Proteine) inhibits colonic biotin uptake via decreasing membrane expression of its transporter and that these effects likely involve a CK2 (zeige CSNK2A1 Proteine)-mediated pathway.
CK2.1 peptide drives chondrogenesis and cartilage formation without induction of chondrocyte hypertrophy by releasing CK2 (zeige CSNK2A1 Proteine) from distinct sites at BMPRIa (zeige BMPR1A Proteine)
showed that inhibition of CK2 (zeige CSNK2A1 Proteine) greatly enhanced M3R (zeige CHRM3 Proteine)-stimulated insulin (zeige INS Proteine) secretion in human islets
CK2-regulated IQJC-SCHIP-1 association with AnkG contributes to axon initial segment maintenance.
We suggest that L1 stimulates neuritogenesis by activating CK2alpha leading to decreased levels of PTEN and p53 (zeige TP53 Proteine) via a novel, L1-triggered and CK2alpha-mediated signal transduction pathway.
our results identify CK2 (zeige CSNK2A1 Proteine) as a novel regulator of TBK1 (zeige TBK1 Proteine) and IRF3 (zeige IRF3 Proteine) and suggest that targeting CK2 (zeige CSNK2A1 Proteine) by small molecular inhibitor may be a viable approach to prevent and treat viral infections.
regulatory(beta) subunit of casein kinase II\; plays a role as a docking site for a subset of CK2 substrates
CK II alpha'
, casein kinase II subunit alpha'
, casein kinase II, alpha 2, polypeptide
, casein kinase 2, alpha prime polypeptide
, casein kinase II subunit alpha'-like
, casein kinase 2 alpha 2
, ck2 alpha'
, CK II
, casein kinase II, alpha' subunit
, LOW QUALITY PROTEIN: casein kinase II subunit alpha'